Risner M E, Goldberg S R
J Pharmacol Exp Ther. 1983 Feb;224(2):319-26.
Beagle dogs pressed a lever under a 15-response fixed-ratio schedule of i.v. nicotine or cocaine infusion or water presentation. A 4-min time-out period followed each fixed-ratio trial and each daily session ended after 16 successive fixed-ratio trials. Both nicotine and cocaine were self-administered above saline levels, with the maximum number of infusions occurring at a dose of 30 micrograms/kg of nicotine and 100 micrograms/kg of cocaine. Rates of responding first increased, reaching a maximum at 10 to 30 micrograms/kg/infusion and then decreased, as the dose of nicotine or cocaine was varied between 3 and 300 micrograms/kg/infusion. The rate of responding and number of infusions obtained per session were higher under the schedule of cocaine self-administration than under the schedule of nicotine self-administration. Presession treatment with the nicotinic antagonist, mecamylamine (1.0 mg/kg i.v.), for seven consecutive sessions, decreased nicotine-maintained responding to levels not unlike those seen when saline was substituted for drug. Neither cocaine- nor water-maintained responding was affected by presession treatment with mecamylamine. A second group of beagle dogs pressed a lever under a schedule of i.v. nicotine (50-400 micrograms/kg/infusion) or cocaine (200-1600 micrograms/kg/infusion) infusion in which the fixed-ratio requirement was increased daily (i.e., a progressive-ratio schedule). The maximum fixed-ratio value at which responding was maintained first increased as the dose per infusion increased and then, at the highest dose, either remained the same or decreased. Cocaine maintained considerably higher fixed-ratio values than did nicotine, but maximum fixed-ratio values for nicotine were well above those seen with saline. The effects of i.v. nicotine (3, 30 or 300 micrograms/kg) or mecamylamine (1.0 mg/kg) on heart rate, rectal temperature and pupillary diameter were measured in a third group of beagle dogs. Nicotine produced dose- and time-related changes in all three physiological parameters; the effects of mecamylamine were considerably greater than those seen with nicotine.
比格犬在静脉注射尼古丁、可卡因或给予水的15次反应固定比率程序下按压杠杆。每次固定比率试验后有一个4分钟的超时阶段,每天的实验在连续16次固定比率试验后结束。尼古丁和可卡因的自我给药量均高于生理盐水水平,尼古丁剂量为30微克/千克、可卡因剂量为100微克/千克时出现的输注次数最多。随着尼古丁或可卡因剂量在3至300微克/千克/输注之间变化,反应率起初上升,在10至30微克/千克/输注时达到最大值,然后下降。与尼古丁自我给药程序相比,可卡因自我给药程序下的反应率和每次实验获得的输注次数更高。连续七次实验前用烟碱拮抗剂美加明(静脉注射1.0毫克/千克)进行预处理,可使尼古丁维持的反应降低至与用生理盐水替代药物时相似的水平。美加明预处理对可卡因维持的反应或水维持的反应均无影响。第二组比格犬在静脉注射尼古丁(50 - 400微克/千克/输注)或可卡因(200 - 1600微克/千克/输注)的程序下按压杠杆,其中固定比率要求每天增加(即累进比率程序)。随着每次输注剂量增加,维持反应的最大固定比率值起初上升,然后在最高剂量时要么保持不变要么下降。可卡因维持的固定比率值比尼古丁高得多,但尼古丁的最大固定比率值远高于生理盐水时的数值。在第三组比格犬中测量了静脉注射尼古丁(3、30或300微克/千克)或美加明(1.0毫克/千克)对心率、直肠温度和瞳孔直径的影响